Dublin, Sept. 13, 2024 (GLOBE NEWSWIRE) -- The "Automatic Data Capture (ADC) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...
Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), licensed its ADC technology to BigHat Biosciences ...
A new family of microcontrollers (MCUs) —the PIC24FJ128GC010 -- is an analog system on chip that integrates an on-chip precision 16-bit ADC and 10 Msps 12-bit ADC, plus a DAC and dual operational ...
Collaboration underscores Lonza's commitment to helping customers deliver innovative new therapies to patients by offering a comprehensive service offering for differentiated ADCs BigHat's artificial ...
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores Lonza’s commitment to helping customers deliver ...
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores Lonza's commitment to helping customers deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results